PHYSIOLOGICAL EFFECTS OF DRUGS
Clinical trials for PHYSIOLOGICAL EFFECTS OF DRUGS explained in plain language.
Never miss a new study
Get alerted when new PHYSIOLOGICAL EFFECTS OF DRUGS trials appear
Sign up with your email to follow new studies for PHYSIOLOGICAL EFFECTS OF DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could dimephosphon help stroke patients recover faster?
Disease control Recruiting nowThis study tests whether the drug Dimephosphon can help people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel in the brain). About 184 adults aged 35-80 who have had a stroke within the last 24-72 hours will receive either Dimephosphon or a place…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Tatchempharmpreparaty, JSC • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
Heart surgery patients may avoid 'Brain Fog' with simple drug
Disease control Recruiting nowThis study tests whether a sedative called dexmedetomidine can prevent long-term memory and thinking problems that often occur after heart surgery. About 2,400 adults aged 60 and older having bypass or valve surgery will receive either dexmedetomidine or a placebo during their op…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
New hope for Treatment-Resistant depression: Fast-Acting drug trial launches
Symptom relief Recruiting nowThis study tests whether a new drug called HNK can quickly improve symptoms in people with major depression that hasn't responded to other treatments. About 50 adults aged 18 to 70 will receive four infusions of HNK and four of a placebo over several weeks, with their depression …
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Neck band breakthrough? new injection study aims to smooth platysma lines
Symptom relief Recruiting nowThis study tests an injection called NT 201 (a type of botulinum toxin) against a placebo to see if it safely reduces the appearance of moderate to severe neck bands (platysma prominence). About 300 adults in Europe will receive either the treatment or a placebo, and doctors and …
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Jun 01, 2026 17:57 UTC
-
NIH launches study to decode depression and suicide risk
Knowledge-focused Recruiting nowThis study follows 500 adults receiving care for depression, bipolar disorder, or suicide risk. Researchers will use interviews, questionnaires, and optional tests like blood draws and brain scans to track how symptoms change over time. The goal is to find better ways to measure …
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC